STOCK TITAN
  1. Home
  2. Sec-filings
  3. TMDX
  4. [SCHEDULE 13G/A] TransMedics Group, Inc. SEC Filing

[SCHEDULE 13G/A] TransMedics Group, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock TMDX logo
Transmedics Group

NASDAQ:TMDX

TMDX Rankings

#1582 Ranked by Market Cap
N/A Ranked by Dividends

TMDX Latest News

Aug 25, 2025
TransMedics to Present at Upcoming September Investor Conferences
Aug 4, 2025
TransMedics Receives FDA IDE Approval to Initiate Next-Generation OCS Heart Trial
Aug 1, 2025
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Jul 30, 2025
TransMedics Reports Second Quarter 2025 Financial Results
Jul 29, 2025
TransMedics to Present at the Canaccord Genuity 45th Annual Growth Conference

TMDX Latest SEC Filings

Aug 8, 2025
[Form 4] TransMedics Group, Inc. Insider Trading Activity
Aug 5, 2025
[Form 4] TransMedics Group, Inc. Insider Trading Activity
Aug 4, 2025
[144] TransMedics Group, Inc. SEC Filing
Jul 30, 2025
[10-Q] TransMedics Group, Inc. Quarterly Earnings Report
Jul 30, 2025
[8-K] TransMedics Group, Inc. Reports Material Event

TMDX Stock Data

3.67B
33.06M
3.01%
111.49%
24.26%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
ANDOVER